Establishing a VTE Risk Score for Astronauts Algorithm

In April 2026, NASA’s Office of the Chief Health and Medical Officer (OCHMO) initiated a working group to review updated VTE case information, additional data gathered revealing altered blood flow status within a cohort of astronauts, and discuss progress of research and clinical activities intended to mitigate the risk of VTE during spaceflight with new evidence-based clinical practice recommendations.

The following is a summary of the working group’s recommendations:

NASA initially formed a working group in October 2024 after diagnosing venous thromboembolisms (VTEs) in astronauts during ISS missions. Experts reviewed case data, updated Clinical Practice Guidelines, and examined possible causes.

Full text from nasa.gov (public domain).